Another approach, potentially improving direct results and late outcome in acromegaly, is the application of intraoperative imaging-guided surgery, targeted at the GHRH receptor in acromegaly, as presently in the investigational stage for detection carcinoma remnants during surgery (Chi et al., 2014). The gene discussed is GHRHR; the disease is acromegaly.